OUR
CONCEPT

THE BIG DATA REVOLUTION

With the big data revolution, the medical and scientific communities have more information to work with than in all of history combined. However, with such a wealth of information, it is increasingly difficult to differentiate productive leads from dead ends.

OWKIN RESPONDS BY MAKING DATA MORE EFFICIENT

Artificial intelligence and machine learning powered by systems biology can organize, validate, predict and compare the overabundance of information. OWKIN builds mathematical models and algorithms that can interpret omics, visual data, biostatistics and patient profiles like never before.

« DATA PRIVACY IS A MAJOR CONCERN »

OWKIN is pioneering federated learning in healthcare to overcome the data sharing problem, building collective intelligence from distributed data.

WE ACCELERATE DRUG DISCOVERY AND OPTIMIZE DRUG DEVELOPMENT TO HELP INDIVIDUAL PATIENTS.

OUR
VISION

OWKIN IMPROVES OUTCOME VIA PREDICTIVE ANALYTICS AND MACHINE LEARNING.

OWKIN learns constantly from heterogeneous data to create unique prediction models, such as those for automated diagnostics, prediction of drug response and toxicity, survival prognostics or clinical trials optimization. OWKIN understands complex data on its own, or in relation to other sets of external data and knowledge. Each patient’s data is “enriched”: when all other available information is overlapped, and our technology detects new patterns from this integrated picture.

HOW MACHINE LEARNING WILL IMPACT THE FUTURE OF MEDICINE ?
TARGET DISCOVERY

Build predictive models to uncover complex patterns of biomarkers

DRUG DESIGN

Design optimal
 molecules in silico to
 achieve high affinity/low toxicity

CLINICAL TRIALS

Predict drug response to design precision clinical trials with optimal outcomes

DRUGS TO PATIENTS

Improve precision medicine finding similar patients

AT EACH STEP, OWKIN PROVIDES INNOVATIVE SERVICES AND PRODUCTS WITH ONLY ONE GOAL IN MIND: IMPROVE PATIENT OUTCOMES.
OUR
PROJECTS
LEARN MORE